Resurgence of pertussis in Slovak Republic and surrounding Central European countries
Acta Microbiologica et Immunologica Hungarica · 2025
DOI: 10.1556/030.2025.02654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2025. Verfasst von Martina Neuschlova und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Pathological Physiology, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Slovak Republic. Hauptthemen laut MEDLINE: Whooping Cough, Bordetella pertussis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: VEGA.
Abstract (Originalsprache)
Bordetella pertussis , the pathogen responsible for a highly contagious respiratory disease, utilizes a broad spectrum of virulence factors that results in subacute or chronic cough. We conducted an analysis of pertussis incidence and reported cases in the European region from 2000 to 2024. We analyzed the potential factors contributing to the rise in pertussis incidence despite high vaccination rates. In 2024, the Slovak Republic and surrounding Central European countries (the Czech Republic, Austria, Hungary, Poland, and Ukraine) have seen a significant increase in pertussis incidence. The results of this study suggest that the resurgence of pertussis was likely due to multiple interacting factors including waning immunity in adults, the genomic changes of B. pertussis , the “immune debt” phenomenon following the lifting of COVID-19 restrictions, the lower vaccination rate against pertussis due to refusal to be vaccinated, a shorter duration of protection offered by acellular vaccines, the transmission of B. pertussis from asymptomatic individuals or patients with mild infection to pertussis-susceptible individuals, as well as improved diagnostics and surveillance. Unimmunised or partially immunised infants are at the highest risk of severe pertussis. The most common sources of infection are family members with asymptomatic or mildly symptomatic disease. All patients with chronic cough should be tested for B. pertussis as part of a comprehensive diagnostic evaluation. To protect newborns, booster vaccination of parents, close family contacts and certain healthcare professionals carrying for the youngest children is recommended. This strategy helps to create a protective environment around infants in the period of pertussis resurgence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Department of Pathological Physiology, Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Slovak Republic.
- 2Clinic of Pediatric Respiratory Diseases and Tuberculosis, National Institute of Pediatric Tuberculosis and Respiratory Diseases, Dolny Smokovec, Comenius University in Bratislava, Jessenius Faculty of Medicine in Mart…
ORCID-Profile: Renata Pecova
Förderung
- VEGA
Zitieren
APA
Neuschlova, M., Kunc, P., & Pecova, R. (2025). Resurgence of pertussis in Slovak Republic and surrounding Central European countries. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2025.02654
Vancouver
Neuschlova M, Kunc P, Pecova R. Resurgence of pertussis in Slovak Republic and surrounding Central European countries. Acta Microbiologica et Immunologica Hungarica. 2025. doi:10.1556/030.2025.02654
BibTeX
@article{Neuschlova2025,
author = {Neuschlova, Martina and Kunc, Peter and Pecova, Renata},
title = {Resurgence of pertussis in Slovak Republic and surrounding Central European countries},
journal = {Acta Microbiologica et Immunologica Hungarica},
year = {2025},
doi = {10.1556/030.2025.02654}
}
EUVIMED